Institutional Review Boards need better, sustained training

The FDA published a 2007 report that noted that the FDA was not conducting adequate review of clinical trials conducted in human subjects. More recently, the US Offices for Human Research Protections and Public Health and Science are working to respond to the findings.

In the latest move the US Offices for Human Research Protections and Public Health and Science are looking at a number of possible measures, including the need to provide guidance on setting up training and educational programmes to make sure individuals involved in the conduct, review and oversight of human clinical research are aware of their regulatory responsibilities

http://www.in-pharmatechnologist.com/news/ng.asp?n=86551-institutional-review-board-clinical-trial-training

KP